MICE TRANSGENIC FOR A SOLUBLE FORM OF MURINE CTLA-4 SHOW ENHANCED EXPANSION OF ANTIGEN-SPECIFIC CD4(+) T-CELLS AND DEFECTIVE ANTIBODY-PRODUCTION IN-VIVO

被引:137
作者
RONCHESE, F
HAUSMANN, B
HUBELE, S
LANE, P
机构
[1] Basel Institute for Immunology, Basel
关键词
D O I
10.1084/jem.179.3.809
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4(+) T cell responses were analyzed in transgenic mice expressing a soluble form of murine CTLA-4, mCTLA4-H gamma 1, which blocks the interaction of the T cell activation molecules CD28 and CTLA-4 with their costimulatory ligands. Consistent with previous reports (Linsley, P. S., P. M. Wallace, J. Johnson, M. G. Gibson, J. L. Greene, J. A. Ledbetter, C. Singh, and M. A. Tepper. 1992. Science (Wash. DC), 257:792), T cell-dependent antibody production was profoundly inhibited in mCTLA4-H gamma 1 transgenic mice immunized with a protein antigen. Surprisingly, however, transgenic mice could generate quantitatively and qualitatively normal primary T cell responses, as measured by limiting dilution assays and lymphokine production. In addition, in vivo expansion of antigen-specific T cells after secondary or tertiary immunization was enhanced in mCTLA4-H gamma 1 transgenics as compared with normal mice. Although unable to deliver cognate help to B cells in vivo, T cells from mCTLA4-H gamma 1 transgenic mice were not anergic as they could help B cells to produce specific antibodies when adoptively transferred into nude hosts. Taken together, these data suggest that the engagement of CD28 and/or CTLA-4 may not be required for, the induction of T cell responses, as is currently understood, but rather for the expression of T cell effector function such as the delivery of T cell help to B cells.
引用
收藏
页码:809 / 817
页数:9
相关论文
共 53 条
  • [1] B70 ANTIGEN IS A 2ND LIGAND FOR CTLA-4 AND CD28
    AZUMA, M
    ITO, D
    YAGITA, H
    OKUMURA, K
    PHILLIPS, JH
    LANIER, LL
    SOMOZA, C
    [J]. NATURE, 1993, 366 (6450) : 76 - 79
  • [2] FUNCTIONAL EXPRESSION OF B7/BB1 ON ACTIVATED LYMPHOCYTES-T
    AZUMA, M
    YSSEL, H
    PHILLIPS, JH
    SPITS, H
    LANIER, LL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (03) : 845 - 850
  • [3] COSTIMULATION OF ANTITUMOR IMMUNITY BY THE B7 COUNTERRECEPTOR FOR THE LYMPHOCYTE-T MOLECULES CD28 AND CTLA-4
    CHEN, LP
    ASHE, S
    BRADY, WA
    HELLSTROM, I
    HELLSTROM, KE
    LEDBETTER, JA
    MCGOWAN, P
    LINSLEY, PS
    [J]. CELL, 1992, 71 (07) : 1093 - 1102
  • [4] 2 TYPES OF MOUSE HELPER T-CELL CLONE .3. FURTHER DIFFERENCES IN LYMPHOKINE SYNTHESIS BETWEEN TH1 AND TH2 CLONES REVEALED BY RNA HYBRIDIZATION, FUNCTIONALLY MONOSPECIFIC BIOASSAYS, AND MONOCLONAL-ANTIBODIES
    CHERWINSKI, HM
    SCHUMACHER, JH
    BROWN, KD
    MOSMANN, TR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (05) : 1229 - 1244
  • [5] CELLULAR SITES OF IMMUNOLOGIC UNRESPONSIVENESS
    CHILLER, JM
    HABICHT, GS
    WEIGLE, WO
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1970, 65 (03) : 551 - &
  • [6] Coffman R L, 1982, Immunol Rev, V69, P5
  • [7] DAMLE NK, 1992, J IMMUNOL, V148, P1985
  • [8] EFFECTS OF CYTO-TOXIC MONOCLONAL-ANTIBODY SPECIFIC FOR T200 GLYCOPROTEIN ON FUNCTIONAL LYMPHOID-CELL POPULATIONS
    DENNERT, G
    HYMAN, R
    LESLEY, J
    TROWBRIDGE, IS
    [J]. CELLULAR IMMUNOLOGY, 1980, 53 (02) : 350 - 364
  • [9] SMALL B-CELLS AS ANTIGEN-PRESENTING CELLS IN THE INDUCTION OF TOLERANCE TO SOLUBLE-PROTEIN ANTIGENS
    EYNON, EE
    PARKER, DC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01) : 131 - 138
  • [10] SELECTIVE INDUCTION OF B7/BB-1 ON INTERFERON-GAMMA STIMULATED MONOCYTES - A POTENTIAL MECHANISM FOR AMPLIFICATION OF T-CELL ACTIVATION THROUGH THE CD28 PATHWAY
    FREEDMAN, AS
    FREEMAN, GJ
    RHYNHART, K
    NADLER, LM
    [J]. CELLULAR IMMUNOLOGY, 1991, 137 (02) : 429 - 437